Clinical Trial Update: Caduet vs Usual Care in Subjects With Hypertension and Additional Risk Factors [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Caduet to usual care in subjects with hypertension and additional risk factors; completed with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia
• Hypertension

Drugs mentioned

• Caduet (amlodipine/atorvastatin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Hypertension, Hypercholesterolemia | Phase 4 | Status: COMPLETED | Results posted: 2011-11-11